207 related articles for article (PubMed ID: 28128455)
1. Expanding the mutation spectrum in ICF syndrome: Evidence for a gender bias in ICF2.
van den Boogaard ML; Thijssen PE; Aytekin C; Licciardi F; Kıykım AA; Spossito L; Dalm VASH; Driessen GJ; Kersseboom R; de Vries F; van Ostaijen-Ten Dam MM; Ikinciogullari A; Dogu F; Oleastro M; Bailardo E; Daxinger L; Nain E; Baris S; van Tol MJD; Weemaes C; van der Maarel SM
Clin Genet; 2017 Oct; 92(4):380-387. PubMed ID: 28128455
[TBL] [Abstract][Full Text] [Related]
2. Subtelomeric methylation distinguishes between subtypes of Immunodeficiency, Centromeric instability and Facial anomalies syndrome.
Toubiana S; Velasco G; Chityat A; Kaindl AM; Hershtig N; Tzur-Gilat A; Francastel C; Selig S
Hum Mol Genet; 2018 Oct; 27(20):3568-3581. PubMed ID: 30010917
[TBL] [Abstract][Full Text] [Related]
3. Comparative methylome analysis of ICF patients identifies heterochromatin loci that require ZBTB24, CDCA7 and HELLS for their methylated state.
Velasco G; Grillo G; Touleimat N; Ferry L; Ivkovic I; Ribierre F; Deleuze JF; Chantalat S; Picard C; Francastel C
Hum Mol Genet; 2018 Jul; 27(14):2409-2424. PubMed ID: 29659838
[TBL] [Abstract][Full Text] [Related]
4. Converging disease genes in ICF syndrome: ZBTB24 controls expression of CDCA7 in mammals.
Wu H; Thijssen PE; de Klerk E; Vonk KK; Wang J; den Hamer B; Aytekin C; van der Maarel SM; Daxinger L
Hum Mol Genet; 2016 Sep; 25(18):4041-4051. PubMed ID: 27466202
[TBL] [Abstract][Full Text] [Related]
5. A novel deletion in ZBTB24 in a Lebanese family with immunodeficiency, centromeric instability, and facial anomalies syndrome type 2.
Chouery E; Abou-Ghoch J; Corbani S; El Ali N; Korban R; Salem N; Castro C; Klayme S; Azoury-Abou Rjeily M; Khoury-Matar R; Debo G; Germanos-Haddad M; Delague V; Lefranc G; Mégarbané A
Clin Genet; 2012 Nov; 82(5):489-93. PubMed ID: 21906047
[TBL] [Abstract][Full Text] [Related]
6. The gene mutations and subtelomeric DNA methylation in immunodeficiency, centromeric instability and facial anomalies syndrome.
Hu H; Chen C; Shi S; Li B; Duan S
Autoimmunity; 2019; 52(5-6):192-198. PubMed ID: 31476899
[TBL] [Abstract][Full Text] [Related]
7. Mutations in ZBTB24 are associated with immunodeficiency, centromeric instability, and facial anomalies syndrome type 2.
de Greef JC; Wang J; Balog J; den Dunnen JT; Frants RR; Straasheijm KR; Aytekin C; van der Burg M; Duprez L; Ferster A; Gennery AR; Gimelli G; Reisli I; Schuetz C; Schulz A; Smeets DFCM; Sznajer Y; Wijmenga C; van Eggermond MC; van Ostaijen-Ten Dam MM; Lankester AC; van Tol MJD; van den Elsen PJ; Weemaes CM; van der Maarel SM
Am J Hum Genet; 2011 Jun; 88(6):796-804. PubMed ID: 21596365
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous clinical presentation in ICF syndrome: correlation with underlying gene defects.
Weemaes CM; van Tol MJ; Wang J; van Ostaijen-ten Dam MM; van Eggermond MC; Thijssen PE; Aytekin C; Brunetti-Pierri N; van der Burg M; Graham Davies E; Ferster A; Furthner D; Gimelli G; Gennery A; Kloeckener-Gruissem B; Meyn S; Powell C; Reisli I; Schuetz C; Schulz A; Shugar A; van den Elsen PJ; van der Maarel SM
Eur J Hum Genet; 2013 Nov; 21(11):1219-25. PubMed ID: 23486536
[TBL] [Abstract][Full Text] [Related]
9. Three novel ZBTB24 mutations identified in Japanese and Cape Verdean type 2 ICF syndrome patients.
Nitta H; Unoki M; Ichiyanagi K; Kosho T; Shigemura T; Takahashi H; Velasco G; Francastel C; Picard C; Kubota T; Sasaki H
J Hum Genet; 2013 Jul; 58(7):455-60. PubMed ID: 23739126
[TBL] [Abstract][Full Text] [Related]
10. Clinical and Immunological Characterization of ICF Syndrome in Japan.
Kamae C; Imai K; Kato T; Okano T; Honma K; Nakagawa N; Yeh TW; Noguchi E; Ohara A; Shigemura T; Takahashi H; Takakura S; Hayashi M; Honma A; Watanabe S; Shigemori T; Ohara O; Sasaki H; Kubota T; Morio T; Kanegane H; Nonoyama S
J Clin Immunol; 2018 Nov; 38(8):927-937. PubMed ID: 30353301
[TBL] [Abstract][Full Text] [Related]
11. CDCA7 and HELLS mutations undermine nonhomologous end joining in centromeric instability syndrome.
Unoki M; Funabiki H; Velasco G; Francastel C; Sasaki H
J Clin Invest; 2019 Jan; 129(1):78-92. PubMed ID: 30307408
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation in disease: Immunodeficiency, Centromeric instability, Facial anomalies syndrome.
Vukic M; Daxinger L
Essays Biochem; 2019 Dec; 63(6):773-783. PubMed ID: 31724723
[TBL] [Abstract][Full Text] [Related]
13. Mutations in CDCA7 and HELLS cause immunodeficiency-centromeric instability-facial anomalies syndrome.
Thijssen PE; Ito Y; Grillo G; Wang J; Velasco G; Nitta H; Unoki M; Yoshihara M; Suyama M; Sun Y; Lemmers RJ; de Greef JC; Gennery A; Picco P; Kloeckener-Gruissem B; Güngör T; Reisli I; Picard C; Kebaili K; Roquelaure B; Iwai T; Kondo I; Kubota T; van Ostaijen-Ten Dam MM; van Tol MJ; Weemaes C; Francastel C; van der Maarel SM; Sasaki H
Nat Commun; 2015 Jul; 6():7870. PubMed ID: 26216346
[TBL] [Abstract][Full Text] [Related]
14. A Novel Mutation in a Critical Region for the Methyl Donor Binding in DNMT3B Causes Immunodeficiency, Centromeric Instability, and Facial Anomalies Syndrome (ICF).
Rechavi E; Lev A; Eyal E; Barel O; Kol N; Barhom SF; Pode-Shakked B; Anikster Y; Somech R; Simon AJ
J Clin Immunol; 2016 Nov; 36(8):801-809. PubMed ID: 27734333
[TBL] [Abstract][Full Text] [Related]
15. A young girl with hypogammaglobulinemia and granulomatous hepatitis caused by a novel mutation in ZBTB24 gene: A case based analysis.
Banday AZ; Jindal AK; Kaur A; Kumar Y; Nameirakpam J; Patra PK; Rawat A
Immunobiology; 2020 May; 225(3):151912. PubMed ID: 32061411
[TBL] [Abstract][Full Text] [Related]
16. Combined immunodeficiency develops with age in Immunodeficiency-centromeric instability-facial anomalies syndrome 2 (ICF2).
von Bernuth H; Ravindran E; Du H; Fröhler S; Strehl K; Krämer N; Issa-Jahns L; Amulic B; Ninnemann O; Xiao MS; Eirich K; Kölsch U; Hauptmann K; John R; Schindler D; Wahn V; Chen W; Kaindl AM
Orphanet J Rare Dis; 2014 Oct; 9():116. PubMed ID: 25330735
[TBL] [Abstract][Full Text] [Related]
17. Three Types of Immunodeficiency, Centromeric Instability, and Facial Anomalies (ICF) Syndrome Identified by Whole-Exome Sequencing in Saudi Hypogammaglobulinemia Patients: Clinical, Molecular, and Cytogenetic Features.
Alghamdi HA; Tashkandi SA; Alidrissi EM; Aledielah RD; AlSaidi KA; Alharbi ES; Habazi MK; Alzahrani MS
J Clin Immunol; 2018 Nov; 38(8):847-853. PubMed ID: 30511102
[No Abstract] [Full Text] [Related]
18. ZBTB24 regulates the apoptosis of human T cells via CDCA7/TRAIL-receptor axis.
Qin XY; Feng J; Chen G; Dou XW; Dai XQ; Dong HL; Gong FY; Xiao F; Zhao Y; Gao XM; Wang J
Biochem Biophys Res Commun; 2019 Jun; 514(1):259-265. PubMed ID: 31030944
[TBL] [Abstract][Full Text] [Related]
19. Roles for Dnmt3b in mammalian development: a mouse model for the ICF syndrome.
Ueda Y; Okano M; Williams C; Chen T; Georgopoulos K; Li E
Development; 2006 Mar; 133(6):1183-92. PubMed ID: 16501171
[TBL] [Abstract][Full Text] [Related]
20. Enhanced CD19 activity in B cells contributes to immunodeficiency in mice deficient in the ICF syndrome gene Zbtb24.
Ying Z; Hardikar S; Plummer JB; Hamidi T; Liu B; Chen Y; Shen J; Mu Y; McBride KM; Chen T
Cell Mol Immunol; 2023 Dec; 20(12):1487-1498. PubMed ID: 37990035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]